Terms: = Breast cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29
221 results:
1. Improving lesion detection in mammograms by leveraging a Cycle-GAN-based lesion remover.
Lee J; Nishikawa RM
Breast Cancer Res; 2024 Feb; 26(1):21. PubMed ID: 38303004
[TBL] [Abstract] [Full Text] [Related]
2. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.
Zhang N; Li Y; Sundquist J; Sundquist K; Ji J
EBioMedicine; 2023 Dec; 98():104859. PubMed ID: 38251461
[TBL] [Abstract] [Full Text] [Related]
3. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
[TBL] [Abstract] [Full Text] [Related]
4. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early breast cancer.
Kyalwazi B; Yau C; Campbell MJ; Yoshimatsu TF; Chien AJ; Wallace AM; Forero-Torres A; Pusztai L; Ellis ED; Albain KS; Blaes AH; Haley BB; Boughey JC; Elias AD; Clark AS; Isaacs CJ; Nanda R; Han HS; Yung RL; Tripathy D; Edmiston KK; Viscusi RK; Northfelt DW; Khan QJ; Asare SM; Wilson A; Hirst GL; Lu R; Symmans WF; Yee D; DeMichele AM; van 't Veer LJ; Esserman LJ; Olopade OI
JAMA Netw Open; 2023 Dec; 6(12):e2349646. PubMed ID: 38153734
[TBL] [Abstract] [Full Text] [Related]
5. Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.
Weng H; Shrestha PR; Hong H; Chen Z; Yu L; Yao Y; Zhang Z; Zou L; Zhu B; Zhou H; Liu X; Liu Y; Guo H; Huang H; Lin T
Cancer Med; 2023 Dec; 12(23):21188-21198. PubMed ID: 37997571
[TBL] [Abstract] [Full Text] [Related]
6. The association between thyroid and breast cancers: a bidirectional mendelian randomization study.
Liu J; Liang L
Front Endocrinol (Lausanne); 2023; 14():1185497. PubMed ID: 37955011
[TBL] [Abstract] [Full Text] [Related]
7. Post-Mastectomy Implant Complications in the Hispanic breast cancer Patient Population.
Conte B; Shermoen C; Lubarsky M; Fiser CK; Liu SN; Kesmodel SB; Goel N; Cerbon D; Wang L
Anticancer Res; 2023 Nov; 43(11):4953-4959. PubMed ID: 37909997
[TBL] [Abstract] [Full Text] [Related]
8. Causal effects of genetically predicted endometriosis on breast cancer: a two-sample Mendelian randomization study.
Yan S; Li J; Chen J; Chen Y; Qiu Y; Zhou Y; Wu W
Sci Rep; 2023 Oct; 13(1):17307. PubMed ID: 37828053
[TBL] [Abstract] [Full Text] [Related]
9. Now or Later? Patient Satisfaction and Anxiety Among Women Undergoing breast Biopsies Performed the Same Day as Recommended Versus a Later Day.
Grimm LJ; Shelby RA; Destounis SV; Knippa EE; Langman EL; Nedrud MA; Musick A; Yoon S; Johnson K; Baker J; Taylor-Cho M; Soo MS
J Am Coll Radiol; 2024 Mar; 21(3):415-424. PubMed ID: 37820836
[TBL] [Abstract] [Full Text] [Related]
10. Native American ancestry and breast cancer risk in Colombian and Mexican women: ruling out potential confounding through ancestry-informative markers.
Zollner L; Torres D; Briceno I; Gilbert M; Torres-Mejía G; Dennis J; Bolla MK; Wang Q; Hamann U; Lorenzo Bermejo J
Breast Cancer Res; 2023 Oct; 25(1):111. PubMed ID: 37784177
[TBL] [Abstract] [Full Text] [Related]
11. Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ.
Koh HH; Yoon SE; Kim SJ; Kim WS; Cho J
Cancer Med; 2023 Oct; 12(19):19732-19743. PubMed ID: 37706649
[TBL] [Abstract] [Full Text] [Related]
12. Impact of Nicotine Replacement Therapy on breast Surgery Outcomes.
Patel SM; Junn A; Sasson D; Dinis J; Duan K; Islam S; Fucito L; Bernstein SL; Hsia HC
J Reconstr Microsurg; 2024 Mar; 40(3):239-244. PubMed ID: 37467771
[TBL] [Abstract] [Full Text] [Related]
13. Investigating Factors Associated with Postmastectomy Emergency Department Visits: A Population-Based Analysis.
Langer S; Xu Y; Kong S; Puddy J; Quan ML
Ann Surg Oncol; 2023 Oct; 30(11):6499-6505. PubMed ID: 37454012
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of the effects of high-intensity interval and moderate-intensity continuous training on inflammatory markers, cardiorespiratory fitness, and quality of life in breast cancer patients.
Isanejad A; Nazari S; Gharib B; Motlagh AG
J Sport Health Sci; 2023 Nov; 12(6):674-689. PubMed ID: 37423313
[TBL] [Abstract] [Full Text] [Related]
15. The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study.
Bryl K; Chimonas S; Li X; Li SQ; Mao JJ
Breast Cancer Res Treat; 2023 Jul; 200(2):257-264. PubMed ID: 37226019
[TBL] [Abstract] [Full Text] [Related]
16. An MRI-Based Radiomics Nomogram to Distinguish Ductal Carcinoma In Situ with Microinvasion From Ductal Carcinoma In Situ of breast cancer.
Wu Z; Lin Q; Wang H; Wang G; Fu G; Bian T
Acad Radiol; 2023 Sep; 30 Suppl 2():S71-S81. PubMed ID: 37211478
[TBL] [Abstract] [Full Text] [Related]
17. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
18. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
[TBL] [Abstract] [Full Text] [Related]
19. Relationship between food-derived antioxidant vitamin intake and breast cancer risk: a mendelian randomized study.
Zhao H; Wu S; Liu H; Luo Z; Sun J; Jin X
Eur J Nutr; 2023 Sep; 62(6):2365-2373. PubMed ID: 37100890
[TBL] [Abstract] [Full Text] [Related]
20. Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.
Wong CY; Leung R; Kwok GW; Tsang J; Li B; Yau T; Chiu J
Postgrad Med J; 2022 Sep; 98(1163):666-669. PubMed ID: 37062975
[TBL] [Abstract] [Full Text] [Related]
[Next]
